Healthcare Industry News

Ista Pharmaceuticals Inc pleaded guilty on Friday to charges it used kickbacks and improper marketing to boost sales of a drug meant to treat eye pain and agreed to pay $33.5 million to settle criminal and civil liability, the U.S. Department of Justice said.

Drug-maker ISTA Pharmaceuticals has pleaded guilty in New York in a federal case involving its eye drug Xibrom and has agreed to pay more than $30 million.

Montrealers participated in a march for the legalization of marijuana, Saturday, May 4, 2013, in Montreal.

LEWISTON, Maine - A Maine hospital group and one of Boston's most prestigious hospitals have announced a collaboration aimed at streamlining services for local cancer patients who need care in Boston.

Healthwatch should have begun representing patients as the Clinical Commissioning Groups took over buying health and social services on April 1. But the body's staff are still not in place and elections to create the group's board are not expected to be completed until the end of July.

The man who famously put down his Big Mac to help rescue three women held captive for a decade in... A New Jersey man will spend the rest of his life behind bars for his role in a crime that left a... A wall is removed from the house that was washed into the Barnegat Bay from Lyman Avenue in Mantoloking during Superstorm Sandy.

Johnson & Johnson is developing what could eventually be game-changing treatments for depression and pain, and it's aiming to apply for approval of more than 10 new medicines by 2017, executives said Thursday during a review of the health care giant's medicine business.

BIG PLANS: Johnson & Johnson says it's poised by 2017 to seek regulatory approval for a dozen new medicines and two dozen variations of existing ones.

Having lived most of her life in this Oklahoma City suburb, Barbara Bryen never feared twisters.

Having lived most of her life in this Oklahoma City suburb, Barbara Bryen never feared twisters.

Jurors in Jodi Arias' murder trial resume deliberations Thursday after they were unable to reach a unanimous verdict on whether she should be sentenced to life in prison or death for killing her one-time... Jurors in Jodi Arias' trial resumed deliberations Thursday, a day after they reported they were unable to reach a unanimous verdict on whether ... (more)

Jurors in Jodi Arias' murder trial resume deliberations Thursday after they were unable to reach a unanimous verdict on whether she should be sentenced to life in prison or death for killing her one-time... Jurors in Jodi Arias' trial resumed deliberations Thursday, a day after they reported they were unable to reach a unanimous verdict on whether ... (more)

Authorities in St. Paul say they've recovered the body of a child missing since a rockslide killed a classmate and left two others injured at a park along the Mississippi River.

Police have arrested two teens suspected in an armed robbery at a Johnson County drugstore that prompted police to lockdown Franklin Community Schools on May 16.

Johnson & Johnson says it plans to submit more than 10 new treatments to regulators for approval and 25 applications for additional uses of approved drugs by 2017.

Existing research shows that bicyclists who wear helmets have an 88 percent lower risk of brain injury, but researchers at Boston Children's Hospital found that simply having bicycle helmet laws in place showed a 20 percent decrease in deaths and injuries for children younger than 16 who were in bicycle-motor vehicle collisions.

A report by the Centers for Disease Control and Prevention is showing a big drop in teen birth rates that some experts say is startling.

Kathrin Jansen is a microbiologist with at least two breakthrough vaccines to her name: she brought the cervical cancer vaccine Gardasil to market for Merck and helped develop the $4 billion a year pneumonia and meningitis vaccine Prevnar 13 for Pfizer.

Drugmaker Pfizer Inc. plans to try to sell its controlling stake in its former animal health business, Zoetis Inc., through a voluntary stock exchange with Pfizer shareholders.

Once perceived as harmless, phthalates have come under increasing scrutiny. A growing collection of evidence suggests dietary exposure to phthalates may cause significant metabolic and hormonal abnormalities, especially during early development.